Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Griffin

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
Value in Health Regional Issues|June 11, 2022
Incorporating Concern for Health Equity Into Resource Allocation Decisions: Development of a Tool and Population-Based Valuation for UgandaFan Yang, Kenneth R Katumba, Giulia Greco, et al.
Health Technology Assessment (Winchester, England)|March 28, 2018
High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluationPedro Saramago, Huiqin Yang, Alexis Llewellyn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage DecisionsKarl Claxton, Stephen Palmer, Louise Longworth, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Health Economics, Policy, and Law|February 18, 2026
Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?Peter Murphy, Susan Griffin, Simon Walker, et al.
Regulatory Toxicology and Pharmacology : RTP|April 3, 2013
The importance of problem formulations in risk assessment: a case study involving dioxin-contaminated soilMichael L Dourson, Bernard Gadagbui, Susan Griffin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2021
Program Evaluation of Population- and System-Level Policies: Evidence for Decision MakingSimon Walker, Aimee Fox, James Altunkaya, et al.
Health Economics|February 19, 2021
Cost-effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross-sectoral analysis of an alcohol misuse interventionFrancesco Ramponi, Simon Walker, Susan Griffin, et al.
Medicine|February 1, 2018
Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countriesLuis Enrique Tierrablanca, Jessica Ochalek, Deborah Ford, et al.
Health Economics|April 12, 2008
Impact of the recall period on measuring health utilities for acute eventsNick Bansback, Huiying Sun, Daphne P Guh, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
Value in Health Regional Issues|June 11, 2022
Incorporating Concern for Health Equity Into Resource Allocation Decisions: Development of a Tool and Population-Based Valuation for UgandaFan Yang, Kenneth R Katumba, Giulia Greco, et al.
Health Technology Assessment (Winchester, England)|March 28, 2018
High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluationPedro Saramago, Huiqin Yang, Alexis Llewellyn, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 8, 2016
A Comprehensive Algorithm for Approval of Health Technologies With, Without, or Only in Research: The Key Principles for Informing Coverage DecisionsKarl Claxton, Stephen Palmer, Louise Longworth, et al.
Pharmacoeconomics|February 6, 2010
Alitretinoin for severe chronic hand eczema: a NICE single technology appraisalMark Rodgers, Susan Griffin, Mike Paulden, et al.
Health Economics, Policy, and Law|February 18, 2026
Cost-effectiveness thresholds in policy and practice: do HTA guidelines align with estimates of health opportunity cost?Peter Murphy, Susan Griffin, Simon Walker, et al.
Regulatory Toxicology and Pharmacology : RTP|April 3, 2013
The importance of problem formulations in risk assessment: a case study involving dioxin-contaminated soilMichael L Dourson, Bernard Gadagbui, Susan Griffin, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 27, 2021
Program Evaluation of Population- and System-Level Policies: Evidence for Decision MakingSimon Walker, Aimee Fox, James Altunkaya, et al.
Health Economics|February 19, 2021
Cost-effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross-sectoral analysis of an alcohol misuse interventionFrancesco Ramponi, Simon Walker, Susan Griffin, et al.
Medicine|February 1, 2018
Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countriesLuis Enrique Tierrablanca, Jessica Ochalek, Deborah Ford, et al.
Health Economics|April 12, 2008
Impact of the recall period on measuring health utilities for acute eventsNick Bansback, Huiying Sun, Daphne P Guh, et al.
Pageof 10